title: [The protective effect of medroxyprogesterone acetate in patients with ovarian cancer treated with chemotherapy].
authors.forename: H
authors.initials: H
authors.lastname: Enzelsberger
authors.forename: P
authors.initials: P
authors.lastname: Sevelda
authors.forename: H
authors.initials: H
authors.lastname: Salzer
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects* / Q000627:therapeutic use; D001853:Bone Marrow / Q000187:drug effects*; D005260:Female; D006410:Hematopoiesis / Q000187:drug effects*; D006801:Humans; D008525:Medroxyprogesterone / Q000031:analogs & derivatives* / Q000627:therapeutic use; D017258:Medroxyprogesterone Acetate; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000188:drug therapy*
chemical_list: D017258:Medroxyprogesterone Acetate; D008525:Medroxyprogesterone
vernacular_title: Schutzeffekt von MPA auf die Hämatotoxizität bei Patientinnen mit Ovarialkarzinom unter Chemotherapie.